|
Oct 9
|
Verrica Pharmaceuticals Inc (VRCA) Q2 2024 Earnings Call Highlights: Revenue Growth Amid Rising ...
|
|
Sep 25
|
Is Verrica Pharmaceuticals Inc. (VRCA) The Worst 52-Week Low Stocks to Buy Now According to Short Sellers?
|
|
Aug 6
|
Verrica Pharmaceuticals to Report Second Quarter Financial Results and Release Preliminary Topline Results from Part 2 of Phase 2 Trial of VP-315 for the Treatment of Basal Cell Carcinoma on August 14, 2024
|
|
Jul 29
|
3 High Insider Ownership US Stocks With Up To 52% Revenue Growth
|
|
Jun 27
|
Recent 12% pullback would hurt Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) insiders
|
|
May 15
|
Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts
|
|
May 14
|
Verrica Pharmaceuticals Inc (VRCA) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
|
|
May 13
|
Verrica Pharmaceuticals Inc (VRCA) Reports Q1 2024 Results: A Detailed Financial Review
|
|
May 13
|
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 13
|
Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results
|
|
May 9
|
Verrica Pharmaceuticals to Present at Upcoming Investor Conferences
|
|
May 8
|
Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
|
|
May 6
|
Verrica Pharmaceuticals (VRCA) Moves 7.4% Higher: Will This Strength Last?
|
|
Apr 25
|
Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?
|
|
Apr 3
|
Strong week for Verrica Pharmaceuticals (NASDAQ:VRCA) shareholders doesn't alleviate pain of three-year loss
|
|
Apr 2
|
Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
|
|
Mar 26
|
Verrica Pharmaceuticals Announces that YCANTH™ Receives New Chemical Entity Status and Orange Book Listing from the FDA
|
|
Feb 29
|
Verrica Pharmaceuticals Inc (VRCA) Reports Fourth Quarter and Full-Year 2023 Financial Results
|
|
Feb 29
|
Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results
|
|
Feb 27
|
Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference
|